Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3 Breast Neoplasms 3 Weight Loss 2 Polyps 2 Hyperplasia 2 Stomach Neoplasms 1 Psoriasis 1 Osteoarthritis 1 Neoplasms 1 Muscular Atrophy 1 Muscle Weakness 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Chronic-Phase 1 Colitis, Ulcerative 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Cancer Cachexia 1 Cachexia 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Anorexia 1 Adenomatous Polyps 1 Adenomatous Polyposis Coli 1

Interventions

Infliximab 6 etrolizumab 5 Adalimumab 4 golimumab 3 Nivolumab 3 CT-P13 3 Specimen Handling 2 Educational Status 2 Colonoscopy 2 vedolizumab 1 pembrolizumab 1 peficitinib 1 cabozantinib 1 Vitamin E 1 Sutures 1 Surgical Instruments 1 Standard of Care 1 Ringer's Lactate 1 Proctocolectomy, Restorative 1 Proctectomy 1 Practice Guidelines as Topic 1 Pneumococcal Vaccines 1 Platinum Compounds 1 Papillomavirus Vaccines 1 Narrow Band Imaging 1 NX-13 1 Methylprednisolone 1 Methods 1 Mesalamine 1 Medical Marijuana 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis, Ulcerative × Eicosapentaenoic Acid × Clear all

NCT02069561 2015-09-18

EPAUC

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Completed

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡